DSS:US
$0.919
5.632%
DSS Inc.News & Events
Last updated: May 11, 2025, 3:01 PM ET
Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FINRA Approval to Act as Underwriter and Selling Group Member for Corporate Securities Offerings
GlobeNewswire APR 24, 2025 8:30 AM EDTNEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sentinel Brokers Company, Inc. (“Sentinel...READ ARTICLEDSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth
GlobeNewswire FEB 26, 2025 8:30 AM ESTROCHESTER, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinationa...READ ARTICLEDSS, Inc. Issues Letter to Shareholders
GlobeNewswire FEB 3, 2025 8:50 AM ESTNEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) a multinational compan...READ ARTICLEDSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value
GlobeNewswire SEP 16, 2024 4:26 PM EDTNEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a dedicated supporte...READ ARTICLEAmericaFirst Funds Trust Announces Changes to Board of Trustees
GlobeNewswire SEP 10, 2024 9:00 AM EDTNEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- AmericaFirst Funds, a subsidiary of DSS, Inc. (NYSE ...READ ARTICLEDSS, Inc. Names Jason Grady as Interim Chief Executive Officer
GlobeNewswire AUG 26, 2024 4:08 PM EDTNEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) has announced the appo...READ ARTICLEDSS, Inc.’s (NYSE American: DSS) Subsidiary Appoints New Chief Investment Officer to Aggressively Develop Mutual Fund Business for Eventual Spinoff
TheNewsWire JUL 27, 2023 9:00 AM EDT(NewsDirect) By David Willey, Benzinga DSS Wealth, Inc. has appointed Danie...READ ARTICLERevenue Increased 72% In Q1 2023 For Premier Packaging Corporation, A DSS, Inc. (NYSE: DSS) Wholly Owned Subsidiary
TheNewsWire JUL 12, 2023 9:00 AM EDT(NewsDirect) By David Willey, Benzinga DSS, Inc. (NYSE American: DSS), a multinationa...READ ARTICLEDSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
TheNewsWire JUN 27, 2023 9:15 AM EDT(NewsDirect) By David Willey, Benzinga DSS, Inc. (NYSE American: DSS) is finalizing t...READ ARTICLEImpact Biomedical Preparing A Potential Spinoff — What Does This Mean For Investors Of Holding Company DSS, Inc (NYSE American: DSS)?
TheNewsWire MAR 27, 2023 9:00 AM EDT(NewsDirect) By Ernest Dela Aglanu, Benzinga Impact Biomedical, a biotechnology company f...READ ARTICLE